SS Innovations International (SSII) Cash from Investing Activities (2017 - 2026)

SS Innovations International's (SSII) quarterly Cash from Investing Activities came in at -$54189.0 in Q1 2026, up 93.79% year-on-year from -$27962.5 in Q1 2025, and up 96.84% quarter-over-quarter from -$1.7 million in Q4 2025.

SS Innovations International (SSII) Cash from Investing Activities (2017 - 2026) Analysis & Trends

SS Innovations International has disclosed Cash from Investing Activities across 10 years of filings, most recently posting -$54189.0 for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$54189.0, up 93.79% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 101.88% YoY), and the FY2025 annual result was -$3.7 million, down 453.16% from the prior year.
  • Cash from Investing Activities came in at -$54189.0 for Q1 2026 at SS Innovations International, up from -$1.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $1.7 million in Q3 2024 to a low of -$2.1 million in Q2 2024.
  • The 5-year median for Cash from Investing Activities is -$127255.0 (2024), against an average of -$331267.5.
  • Across the five-year window, Cash from Investing Activities tumbled 6329.8% in 2023 and jumped 872.1% in 2024, its largest moves.
  • SS Innovations International's Cash from Investing Activities stood at -$137530.0 in 2022, then rose by 7.48% to -$127249.0 in 2023, then climbed by 1.66% to -$125142.0 in 2024, then plunged by 1270.07% to -$1.7 million in 2025, then jumped by 96.84% to -$54189.0 in 2026.
  • The last three Cash from Investing Activities figures came in at -$54189.0 (Q1 2026), -$1.7 million (Q4 2025), and -$755075.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -20.32 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -185.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -92.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -298.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -2.50 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -217.20 Mn
10 SS Innovations International 689.95 Mn 666.34 Mn 5.33 Mn -54,189.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -54,189.00
Mar 31, 2026 -54,189.00
Dec 31, 2025 -1.71 Mn
Dec 31, 2025 -1.71 Mn
Sep 30, 2025 -755,075.00
Sep 30, 2025 -755,075.00
Jun 30, 2025 -316,648.00
Jun 30, 2025 -316,648.00
Mar 31, 2025 -872,804.00
Mar 31, 2025 -872,804.00
Dec 31, 2024 -125,142.00
Dec 31, 2024 -125,142.00
Sep 30, 2024 1.70 Mn
Sep 30, 2024 1.70 Mn
Jun 30, 2024 -2.11 Mn
Jun 30, 2024 -2.11 Mn
Mar 31, 2024 -127,255.00
Mar 31, 2024 -127,255.00
Dec 31, 2023 -127,249.00
Dec 31, 2023 -127,249.00